Acasti Pharma Awarded Broad Composition-of-Matter and Method of Use Patents by the European Patent Office – Nasdaq

Acasti Pharma Awarded Broad Composition-of-Matter and Method of Use Patents by the European Patent Office  Nasdaq

LAVAL, Québec, Jan. 09, 2019– Acasti Pharma Inc., a biopharmaceutical innovator focused on the research, development and commercialization of its.